knowledge -WSS

knowledge

author：leisure time 2025-09-27 19:38:19 - browse：4

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How digital therapeutics firms are pivoting after Pear's bankruptcy

hotspot

WSS

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Burning questions for the 2024 JPM Healthcare Conference

Morgan Health, with ambitious aims, wants you to know it’s still here

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Copay coupons to count toward deductibles, after Biden court move

A single drug, study failures leave Anavex with nothing but cash

explore

knowledge

focus

New air purifier tech could be key to improving indoor air quality

Parkinson’s finding may lead to tests and, someday, treatments

After affirmative action ruling, medical educators look to 'holistic review'

AI generated plenty of interest at JPM but not a lot of trust

Medical leaders decry Supreme Court decision on affirmative action

3 medical device trends to watch in 2024

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The tragedy of Johnson & Johnson’s Covid vaccine

Walensky prepares to leave CDC — and Congress — behind

White House finalizes ITC's import ban of latest Apple Watches

focus

Goldman Sachs launches $650M fund for life science investments

Biotech venture capitalists face new demands from investors

Ahead of JPM, here's who's profiting most in health care

New brain studies show LSD's effects on the brain in full color

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

eGenesis tests gene

hotspot

Wikipedia

hotspot

focus